Kuramochi H, Yamada T, Yoshida Y, Matsuda A, et al. The Pre-treatment Lymphocyte-to-Monocyte Ratio Predicts Efficacy in Metastatic Colorectal Cancer Treated With TAS-102 and Bevacizumab. Anticancer Res 2021;41:3131-3137.
PMID: 34083307